Skip to main content

Table 5 Relationship between ePWV and 1-year mortality in different subgroups

From: Association between estimated pulse wave velocity and the risk of mortality in patients with subarachnoid hemorrhage: a retrospective cohort study based on the MIMIC database

ePWV levels

HR (95% CI)

P

HR (95% CI)

P

 

< 65 years old

≥ 65 years old

< 10.12

Ref

 

Ref

 

[10.12–12.10)

2.64 (1.70–4.09)

< 0.001

1.23 (0.73–2.04)

0.436

≥ 12.10

2.55 (1.01–6.44)

0.048

2.57 (1.59–4.15)

< 0.001

 

SOFA < 2

SOFA ≥ 2

< 10.12

Ref

 

Ref

 

[10.12–12.10)

1.09 (0.68–1.76)

0.721

1.43 (0.94–2.19)

0.098

≥ 12.10

2.19 (1.26–3.81)

0.005

1.50 (0.90–2.50)

0.116

 

Non-surgery

Surgery

< 10.12

Ref

 

Ref

 

[10.12–12.10)

1.38 (1.01–1.90)

0.050

1.00 (0.19–5.36)

0.998

≥ 12.10

2.02 (1.39–2.94)

< 0.001

2.65 (0.25–28.46)

0.420

 

Non-AF

AF

< 10.12

Ref

 

Ref

 

[10.12–12.10)

1.39 (1.00-1.92)

0.051

1.73 (0.50–6.05)

0.389

≥ 12.10

1.95 (1.32–2.89)

< 0.001

3.64 (0.80-16.62)

0.095

 

Non-RF

RF

< 10.12

Ref

 

Ref

 

[10.12–12.10)

1.21 (0.84–1.72)

0.305

2.97 (1.37–6.45)

0.006

≥ 12.10

1.98 (1.28–3.04)

0.002

2.12 (0.87–5.20)

0.099

 

Non-hepatic diseases

Hepatic diseases

< 10.12

Ref

 

Ref

 

[10.12–12.10)

1.39 (1.01–1.94)

0.048

1.29 (0.35–4.79)

0.703

≥ 12.10

2.11 (1.43–3.11)

< 0.001

0.09 (0.01–0.70)

0.021

 

Non-COPD

COPD

< 10.12

Ref

 

Ref

 

[10.12–12.10)

1.47 (1.05–2.06)

0.024

0.56 (0.20–1.52)

0.255

≥ 12.10

2.29 (1.55–3.38)

< 0.001

0.52 (0.14–1.92)

0.328

 

Non-sepsis

Sepsis

< 10.12

Ref

 

Ref

 

[10.12–12.10)

1.24 (0.78–1.98)

0.359

1.27 (0.80-2.00)

0.308

≥ 12.10

1.79 (1.00-3.21)

0.050

2.17 (1.30–3.62)

0.003

 

Non-hypertension

Hypertension

< 10.12

Ref

 

Ref

 

[10.12–12.10)

1.53 (0.94–2.50)

0.088

1.28 (0.84–1.95)

0.246

≥ 12.10

3.49 (1.95–6.23)

< 0.001

1.58 (0.96–2.62)

0.074

 

Non-DM

DM

< 10.12

Ref

 

Ref

 

[10.12–12.10)

1.40 (1.01–1.96)

0.046

1.21 (0.45–3.25)

0.711

≥ 12.10

2.28 (1.53–3.40)

< 0.001

1.66 (0.55–5.04)

0.370

  1. ePWV: estimated pulse wave velocity, SAH: subarachnoid hemorrhage, HR: hazard ratio, CI: confidence interval, Ref: reference
  2. Age subgroups adjusted for: ICU types, HF, AF, RF, hepatic diseases, COPD, sepsis, hypertension, DM, malignancy, HR, RR, temperature, SOFA, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT;
  3. SOFA subgroups adjusted for: age, ICU types, HF, AF, RF, hepatic diseases, COPD, sepsis, hypertension, DM, malignancy, HR, RR, temperature, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT;
  4. Surgery subgroups adjusted for: age, ICU types, HF, AF, RF, hepatic diseases, COPD, sepsis, hypertension, DM, malignancy, HR, RR, temperature, SOFA, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT;
  5. AF subgroups adjusted for: age, ICU types, HF, RF, hepatic diseases, COPD, sepsis, hypertension, DM, malignancy, HR, RR, temperature, SOFA, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT;
  6. RF subgroups adjusted for: age, ICU types, HF, AF, hepatic diseases, COPD, sepsis, hypertension, DM, malignancy, HR, RR, temperature, SOFA, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT;
  7. Hepatic diseases subgroups adjusted for: age, ICU types, HF, AF, RF, COPD, sepsis, hypertension, DM, malignancy, HR, RR, temperature, SOFA, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT;
  8. COPD subgroups adjusted for: age, ICU types, HF, AF, RF, hepatic diseases, sepsis, hypertension, DM, malignancy, HR, RR, temperature, SOFA, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT;
  9. Sepsis subgroups adjusted for: age, ICU types, HF, AF, RF, hepatic diseases, COPD, hypertension, DM, malignancy, HR, RR, temperature, SOFA, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT;
  10. Hypertension subgroups adjusted for: age, ICU types, HF, AF, RF, hepatic diseases, COPD, sepsis, DM, malignancy, HR, RR, temperature, SOFA, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT;
  11. DM subgroups adjusted for: age, ICU types, HF, AF, RF, hepatic diseases, COPD, sepsis, hypertension, malignancy, HR, RR, temperature, SOFA, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT